C125H145ClF6N36O6 — CID 167584438
N-(4-chloro-3-methylphenyl)-4-methyl-3-[[1-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]imidazol-2-yl]amino]benzamide;3-[[1-[6-(cyclopropylamino)pyrimidin-4-yl]imidazol-2-yl]amino]-N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[[1-[6-(cyclopropylamino)pyrimidin-4-yl]imidazol-2-yl]amino]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]benzamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-[[1-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]imidazol-2-yl]amino]benzamide (PubChem CID 167584438) has the molecular formula C125H145ClF6N36O6 and a molecular weight of 2397.22 g/mol. Its IUPAC name is N-(4-chloro-3-methylphenyl)-4-methyl-3-[[1-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]imidazol-2-yl]amino]benzamide;3-[[1-[6-(cyclopropylamino)pyrimidin-4-yl]imidazol-2-yl]amino]-N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[[1-[6-(cyclopropylamino)pyrimidin-4-yl]imidazol-2-yl]amino]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]benzamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-[[1-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]imidazol-2-yl]amino]benzamide.
| Compound Name | N-(4-chloro-3-methylphenyl)-4-methyl-3-[[1-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]imidazol-2-yl]amino]benzamide;3-[[1-[6-(cyclopropylamino)pyrimidin-4-yl]imidazol-2-yl]amino]-N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[[1-[6-(cyclopropylamino)pyrimidin-4-yl]imidazol-2-yl]amino]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]benzamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-[[1-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]imidazol-2-yl]amino]benzamide |
|---|---|
| PubChem CID | 167584438 |
| Molecular Formula | C125H145ClF6N36O6 |
| Molecular Weight | 2397.22 g/mol |
| Exact Mass | 2395.17 |
| IUPAC Name | N-(4-chloro-3-methylphenyl)-4-methyl-3-[[1-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]imidazol-2-yl]amino]benzamide;3-[[1-[6-(cyclopropylamino)pyrimidin-4-yl]imidazol-2-yl]amino]-N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[[1-[6-(cyclopropylamino)pyrimidin-4-yl]imidazol-2-yl]amino]-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]benzamide;N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-[[1-[6-(2-morpholin-4-ylethylamino)pyrimidin-4-yl]imidazol-2-yl]amino]benzamide |
| SMILES | CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(Nc4nccn4-c4cc(NC5CC5)ncn4)c3)cc2C(F)(F)F)CC1.CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(Nc4nccn4-c4cc(NCCN5CCOCC5)ncn4)c3)cc2C(F)(F)F)CC1.Cc1cc(NC(=O)c2ccc(C)c(Nc3nccn3-c3cc(NCCN4CCOCC4)ncn3)c2)ccc1Cl.Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccn1-c1cc(NC2CC2)ncn1 |
| InChI | InChI=1S/C35H43F3N10O2.C32H36F3N9O.C30H35N9O.C28H31ClN8O2/c1-3-45-12-14-47(15-13-45)23-27-6-7-28(21-29(27)35(36,37)38)43-33(49)26-5-4-25(2)30(20-26)44-34-40-9-11-48(34)32-22-31(41-24-42-32)39-8-10-46-16-18-50-19-17-46;1-3-42-12-14-43(15-13-42)19-23-6-7-25(17-26(23)32(33,34)35)40-30(45)22-5-4-21(2)27(16-22)41-31-36-10-11-44(31)29-18-28(37-20-38-29)39-24-8-9-24;1-21-3-6-23(29(40)35-25-7-4-22(5-8-25)19-38-15-13-37(2)14-16-38)17-26(21)36-30-31-11-12-39(30)28-18-27(32-20-33-28)34-24-9-10-24;1-19-3-4-21(27(38)34-22-5-6-23(29)20(2)15-22)16-24(19)35-28-31-8-10-37(28)26-17-25(32-18-33-26)30-7-9-36-11-13-39-14-12-36/h4-7,9,11,20-22,24H,3,8,10,12-19,23H2,1-2H3,(H,40,44)(H,43,49)(H,39,41,42);4-7,10-11,16-18,20,24H,3,8-9,12-15,19H2,1-2H3,(H,36,41)(H,40,45)(H,37,38,39);3-8,11-12,17-18,20,24H,9-10,13-16,19H2,1-2H3,(H,31,36)(H,35,40)(H,32,33,34);3-6,8,10,15-18H,7,9,11-14H2,1-2H3,(H,31,35)(H,34,38)(H,30,32,33) |
| InChIKey | HPGXLWDAIIUBTP-UHFFFAOYSA-N |
| XLogP | 19.53 |
| TPSA | 431.42 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 40 |
| Heavy Atoms | 174 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2397.22 |
| LogP ≤ 5 | 19.53 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 38 |